Ménière's disease

Last updated

Ménière's disease
SynonymsMénière's syndrome, idiopathic endolymphatic hydrops [1]
Balance Disorder Illustration A.png
Diagram of the inner ear
Pronunciation
Specialty Otolaryngology
Symptoms Feeling like the world is spinning, ringing in the ears, hearing loss, fullness in the ear [3] [4]
Usual onset40s–60s [3]
Duration20 minutes to few hours per episode [5]
CausesUnknown [3]
Risk factors Family history [4]
Diagnostic method Based on symptoms, hearing test [3]
Differential diagnosis Vestibular migraine, transient ischemic attack [1]
TreatmentLow salt diet, diuretics, corticosteroids, counselling [3] [4]
PrognosisAfter ~10 years hearing loss and chronic ringing [5]
Frequency0.3–1.9 per 1,000 [1]

Ménière's disease (MD) is a disorder of the inner ear that is characterized by episodes of feeling like the world is spinning (vertigo), ringing in the ears (tinnitus), hearing loss, and a fullness in the ear. [3] [4] Typically only one ear is affected, at least initially; however, over time both ears may become involved. [3] Episodes generally last from 20 minutes to a few hours. [5] The time between episodes varies. [3] Over time the hearing loss and ringing in the ears may become constant. [4]

Inner ear innermost part of the vertebrate ear

The inner ear is the innermost part of the vertebrate ear. In vertebrates, the inner ear is mainly responsible for sound detection and balance. In mammals, it consists of the bony labyrinth, a hollow cavity in the temporal bone of the skull with a system of passages comprising two main functional parts:

Vertigo Type of dizziness where a person feels as if they or the objects around them are moving

Vertigo is a symptom where a person feels as if they or the objects around them are moving when they are not. Often it feels like a spinning or swaying movement. This may be associated with nausea, vomiting, sweating, or difficulties walking. It is typically worse when the head is moved. Vertigo is the most common type of dizziness.

Tinnitus perception of sound within the human ear ("ringing of the ears") when no external sound is present

Tinnitus is the hearing of sound when no external sound is present. While often described as a ringing, it may also sound like a clicking, hiss or roaring. Rarely, unclear voices or music are heard. The sound may be soft or loud, low pitched or high pitched and appear to be coming from one ear or both. Most of the time, it comes on gradually. In some people, the sound causes depression or anxiety and can interfere with concentration.

Contents

The cause of Ménière's disease is unclear but likely involves both genetic and environmental factors. [1] [3] A number of theories exist for why it occurs including constrictions in blood vessels, viral infections, and autoimmune reactions. [3] About 10% of cases run in families. [4] Symptoms are believed to occur as the result of increased fluid build up in the labyrinth of the inner ear. [3] Diagnosis is based on the symptoms and frequently a hearing test. [3] Other conditions that may produce similar symptoms include vestibular migraine and transient ischemic attack. [1]

Membranous labyrinth system of tubes and chambers in the inner ear

The membranous labyrinth is a collection of fluid filled tubes and chambers which contain the receptors for the senses of equilibrium and hearing. It is lodged within the bony labyrinth in the inner ear and has the same general form; it is, however, considerably smaller and is partly separated from the bony walls by a quantity of fluid, the perilymph.

Hearing test A hearing test provides an evaluation of the sensitivity of a persons sense of hearing and is most often performed by an audiologist using an audiometer.

A hearing test provides an evaluation of the sensitivity of a person's sense of hearing and is most often performed by an audiologist using an audiometer. An audiometer is used to determine a person's hearing sensitivity at different frequencies. There are other hearing tests as well, e.g., Weber test and Rinne test.

A transient ischemic attack (TIA) is a brief episode of neurological dysfunction caused by loss of blood flow (ischemia) in the brain, spinal cord, or retina, without tissue death (infarction). TIAs have the same underlying mechanism as ischemic strokes. Both are caused by a disruption in blood flow to the brain, or cerebral blood flow (CBF). The definition of TIA was classically based on duration of neurological symptoms. The current widely-accepted definition is called "tissue-based" because it is based on imaging, not time. The American Heart Association and the American Stroke Association (AHA/ASA) now define TIA as a brief episode of neurological dysfunction with a vascular cause, with clinical symptoms typically lasting less than one hour, and without evidence of infarction on imaging.

There is no known cure. [3] Attacks are often treated with medications to help with the nausea and anxiety. [4] Measures to prevent attacks are overall poorly supported by the evidence. [4] A low salt diet, diuretics, and corticosteroids may be tried. [4] Physical therapy may help with balance and counselling may help with anxiety. [3] [4] Injections into the ear or surgery may also be tried if other measures are not effective but are associated with risks. [3] [5] The use of tympanostomy tubes, while popular, is not supported. [5]

Nausea medical symptom or condition

Nausea is an unpleasant, diffuse sensation of unease and discomfort, often perceived as an urge to vomit. While not painful, it can be a debilitating symptom if prolonged, and has been described as placing discomfort on the chest, upper abdomen, or back of the throat.

Corticosteroid steroid hormone

Corticosteroids are a class of steroid hormones that are produced in the adrenal cortex of vertebrates, as well as the synthetic analogues of these hormones. Two main classes of corticosteroids, glucocorticoids and mineralocorticoids, are involved in a wide range of physiological processes, including stress response, immune response, and regulation of inflammation, carbohydrate metabolism, protein catabolism, blood electrolyte levels, and behavior.

Physical therapy primary care specialty remediates impairments and promotes mobility and working function of the body

Physical therapy (PT), also known as physiotherapy, is one of the allied health professions that, by using mechanical force and movements, manual therapy, exercise therapy, and electrotherapy, remediates impairments and promotes mobility and function. Physical therapy is used to improve a patient's quality of life through examination, diagnosis, prognosis, physical intervention, and patient education. It is performed by physical therapists.

Ménière's disease was first identified in the early 1800s by Prosper Ménière. [5] It affects between 0.3 and 1.9 per 1,000 people. [1] It most often starts in people 40 to 60 years old. [3] Females are more commonly affected than males. [1] After 5 to 15 years of symptoms, the episodes of the world spinning generally stop and the person is left with mild loss of balance, moderately poor hearing in the affected ear, and ringing in their ear. [5]

Prosper Ménière French physician

Prosper Ménière was a French doctor who first identified a medical condition combining vertigo, hearing loss and tinnitus, which is now known as Ménière's disease.

Signs and symptoms

Ménière's is characterized by recurrent episodes of vertigo, hearing loss and tinnitus; episodes may be accompanied by a headache and a feeling of fullness in the ears. [4]

People may also experience additional symptoms related to irregular reactions of the autonomic nervous system. These symptoms are not symptoms of Meniere's disease per se, but rather are side effects resulting from failure of the organ of hearing and balance, and include nausea, vomiting, and sweating—which are typically symptoms of vertigo, and not of Ménière's. [1] This includes a sensation of being pushed sharply to the floor from behind. [5]

Autonomic nervous system division of the peripheral nervous system

The autonomic nervous system (ANS), formerly the vegetative nervous system, is a division of the peripheral nervous system that supplies smooth muscle and glands, and thus influences the function of internal organs. The autonomic nervous system is a control system that acts largely unconsciously and regulates bodily functions such as the heart rate, digestion, respiratory rate, pupillary response, urination, and sexual arousal. This system is the primary mechanism in control of the fight-or-flight response.

Vomiting involuntary, forceful expulsion of stomach contents, typically via the mouth

Vomiting is the involuntary, forceful expulsion of the contents of one's stomach through the mouth and sometimes the nose.

Sudden falls without loss of consciousness (drop attacks) may be experienced by some people. [1]

Causes

The cause of Ménière's disease is unclear but likely involves both genetic and environmental factors. [1] [3] A number of theories exist including constrictions in blood vessels, viral infections, autoimmune reactions. [3]

Mechanism

Inner ear Vestibular system's semicircular canal- a cross-section.jpg
Inner ear

The initial triggers of Ménière's disease are not fully understood, with a variety of potential inflammatory causes that lead to endolymphatic hydrops (EH), a distension of the endolymphatic spaces in the inner ear. EH, in turn, is strongly associated with developing MD, [1] but not everyone with EH develops MD: "The relationship between endolymphatic hydrops and Meniere's disease is not a simple, ideal correlation." [6]

Additionally, in fully developed MD the balance system (vestibular system) and the hearing system (cochlea) of the inner ear are affected, but there are cases where EH affects only one of the two systems strong enough to cause symptoms. The corresponding subtypes of MD are called vestibular MD, showing symptoms of vertigo, and cochlear MD, showing symptoms of hearing loss and tinnitus. [7] [8] [9] [10]

The mechanism of MD is not fully explained by EH, but fully developed EH may mechanically and chemically interfere with the sensory cells for balance and hearing, which can lead to temporary dysfunction and even to death of the sensory cells, which in turn can cause the typical symptoms of MD: vertigo, hearing loss, and tinnitus. [8] [6]

Diagnosis

Audiograms illustrating normal hearing (left) and unilateral low-pitch hearing loss associated with Meniere's disease (right) Menieres-hearing-loss.png
Audiograms illustrating normal hearing (left) and unilateral low-pitch hearing loss associated with Ménière's disease (right)
Loudness discomfort levels (LDLs): data of people with hyperacusis without hearing loss. Upper line: average hearing thresholds. Lower long line: LDLs of this group. Lower short line: LDLs of a reference group with normal hearing. LDL-Audiogram.jpg
Loudness discomfort levels (LDLs): data of people with hyperacusis without hearing loss. Upper line: average hearing thresholds. Lower long line: LDLs of this group. Lower short line: LDLs of a reference group with normal hearing.

The diagnostic criteria as of 2015 define definite MD and probable MD as follows: [1] [4]

Definite

  1. Two or more spontaneous episodes of vertigo, each lasting 20 minutes to 12 hours
  2. Audiometrically documented low- to medium-frequency sensorineural hearing loss in the affected ear on at least 1 occasion before, during, or after one of the episodes of vertigo
  3. Fluctuating aural symptoms (hearing, tinnitus, or fullness) in the affected ear
  4. Not better accounted for by another vestibular diagnosis

Probable

  1. Two or more episodes of vertigo or dizziness, each lasting 20 minutes to 24 hours
  2. Fluctuating aural symptoms (hearing, tinnitus, or fullness) in the reported ear
  3. Not better accounted for by another vestibular diagnosis

A common and important symptom of MD is hypersensitivity to sounds. [12] This hypersensitivity is easily diagnosed by measuring the loudness discomfort levels (LDLs). [13]

Symptoms of MD overlap with migraine-associated vertigo (MAV) in many ways, but when hearing loss develops in MAV is usually in both ears, and this is rare in MD, and hearing loss generally does not progress in MAV as it does in MD. [1]

People who have had a transient ischemic attack (TIA) or stroke can present with symptoms similar to MD, and in people at risk magnetic resonance imaging (MRI) should be conducted to exclude TIA or stroke. [1]

Other vestibular conditions that should be excluded include vestibular paroxysmia, recurrent unilateral vestibulopathy, vestibular schwannoma, or a tumor of the endolymphatic sac. [1]

Management

There is no cure for Ménière's disease but medications, diet, physical therapy and counseling, and some surgical approaches can be used to manage it. [4]

Medications

During MD episodes, medications to reduce nausea are used, as are drugs to reduce the anxiety caused by vertigo. [4] [14]

For longer-term treatment to stop progression, the evidence base is weak for all treatments. [4]

Although a causal relation between allergy and Ménière's disease is uncertain, medication to control allergies may be helpful. [15]

Diuretics, such as the thiazide-like diuretic chlortalidone, are widely used to manage Ménière's on the theory that it reduces fluid buildup in the ear. Based on evidence from multiple but small clinical trials, diuretics appear to be useful for reducing the frequency of episodes of dizziness but do not seem to prevent hearing loss. [16]

In cases where there is hearing loss and continuing severe episodes of vertigo, a chemical labyrinthectomy, in which a medication such as gentamicin is injected into the middle ear and kills parts of the vestibular apparatus. [4] [17] [18] This treatment has the risk of worsening hearing loss. [17]

Diet

People with MD are often advised to reduce their salt intake. [14] [19] Reducing salt intake, however, has not been well studied. [19] Based on the assumption that MD is similar in nature to a migraine, some advise eliminating "migraine triggers" like caffeine. However, the evidence for this is weak. [14]

Physical therapy

While use of physical therapy early after the onset of MD is probably not useful due to the fluctuating disease course, physical therapy to help retraining of the balance system appears to be useful to reduce both subjective and objective deficits in balance over the longer term. [4] [20]

Counselling

The psychological distress caused by the vertigo and hearing loss may worsen the condition in some people. [21] Counseling may be useful to manage the distress, [4] as may education and relaxation techniques. [22]

Surgery

If symptoms do not improve with typical treatment, surgery may be considered. [4] Surgery to decompress the endolymphatic sac is one option. A systematic review in 2015 found that three methods of decompression have been used: simple decompression, insertion of a shunt; and removal of the sac. [23] It found some evidence that all three methods were useful for reducing dizziness, but that the level of evidence was low, as trials were not blinded nor were there placebo controls. [23]

Another 2015 review found that shunts used in these surgeries often turn out to be displaced or misplaced in autopsies, and recommended their use only in cases where the condition is uncontrolled and affecting both ears. [14] A systematic review from 2014 found that in at least 75% of people EL sac decompression was effective at controlling vertigo in the short term (>1 year of follow-up) and long term (>24 months). [24]

It has been estimated that about 30% of people with Meniere's disease have eustachian tube dysfunction. [25] While a 2005 review found tentative evidence of benefit from tympanostomy tubes for improvement in the unsteadiness associated with the disease, [25] a 2014 review concluded that they are not supported. [5]

Destructive surgeries are irreversible and involve removing entire functionality of most, if not all, of the affected ear; as of 2013, there was almost no evidence with which to judge whether these surgeries are effective. [26] The inner ear itself can be surgically removed via labyrinthectomy, although hearing is always completely lost in the affected ear with this operation. [26] The surgeon can also cut the nerve to the balance portion of the inner ear in a vestibular neurectomy. The hearing is often mostly preserved; however, the surgery involves cutting open into the lining of the brain, and a hospital stay of a few days for monitoring would be required. [26]

Poorly supported

Prognosis

Ménière's disease usually starts confined to one ear; it appears that it extends to both ears in about 30% of cases. [5]

People may start out with only one symptom, but in MD all three appear with time. [5] Hearing loss usually fluctuates in the beginning stages and becomes more permanent in later stages. MD has a course of 5–15 years, and people generally end up with mild disequilibrium, tinnitus, and moderate hearing loss in one ear. [5]

Epidemiology

From 3% to 11% of diagnosed dizziness in neuro-otological clinics are due to Meniere's. [33] The annual incidence rate is estimated to be about 15/100,000 and the prevalence rate is about 218/100,000, and around 15% of people with Meniere's disease are older than 65. [33] In around 9% of cases a relative also had MD, signalling that there may be a genetic predisposition in some cases. [4]

The odds of MD are greater for people of white ethnicity, with severe obesity, and women. [1] Several conditions are often comorbid with MD, including arthritis, psoriasis, gastroesophageal reflux disease, irritable bowel syndrome, and migraine. [1]

History

The condition is named after the French physician Prosper Ménière, who in an 1861 article described the main symptoms and was the first to suggest a single disorder for all of the symptoms, in the combined organ of balance and hearing in the inner ear. [34] [35]

The American Academy of Otolaryngology–Head and Neck Surgery Committee on Hearing and Equilibrium (AAO HNS CHE) set criteria for diagnosing Ménière's, as well as defining two sub-categories of Ménière's: cochlear (without vertigo) and vestibular (without deafness). [36]

In 1972, the Academy defined criteria for diagnosing Ménière's disease as: [36]

  1. Fluctuating, progressive, sensorineural deafness.
  2. Episodic, characteristic definitive spells of vertigo lasting 20 minutes to 24 hours with no unconsciousness, vestibular nystagmus always present.
  3. Tinnitus (ringing in the ears, from mild to severe) Often the tinnitus is accompanied by ear pain and a feeling of fullness in the affected ear. Usually, the tinnitus is more severe before a spell of vertigo and lessens after the vertigo attack.
  4. Attacks are characterized by periods of remission and exacerbation.

In 1985, this list changed to alter wording, such as changing "deafness" to "hearing loss associated with tinnitus, characteristically of low frequencies" and requiring more than one attack of vertigo to diagnose. [36] Finally in 1995, the list was again altered to allow for degrees of the disease: [36]

  1. Certain – Definite disease with histopathological confirmation
  2. Definite – Requires two or more definitive episodes of vertigo with hearing loss plus tinnitus and/or aural fullness
  3. Probable – Only one definitive episode of vertigo and the other symptoms and signs
  4. Possible – Definitive vertigo with no associated hearing loss

In 2015, the International Classification for Vestibular Disorders Committee of the Barany Society published consensus diagnostic criteria in collaboration with the American Academy of Otolaryngology – Head and Neck Surgery, the European Academy of Otology & Neuro-Otology, the Japan Society for Equilibrium Research, and the Korean Balance Society. [1] [4]

Related Research Articles

Ototoxicity is the property of being toxic to the ear (oto-), specifically the cochlea or auditory nerve and sometimes the vestibular system, for example, as a side effect of a drug. The effects of ototoxicity can be reversible and temporary, or irreversible and permanent. It has been recognized since the 19th century. There are many well-known ototoxic drugs used in clinical situations, and they are prescribed, despite the risk of hearing disorders, to very serious health conditions. Ototoxic drugs include antibiotics such as gentamicin, loop diuretics such as furosemide and platinum-based chemotherapy agents such as cisplatin. A number of nonsteroidal anti-inflammatory drugs (NSAIDS) have also been shown to be ototoxic. This can result in sensorineural hearing loss, dysequilibrium, or both. Some environmental and occupational chemicals have also been shown to affect the auditory system and interact with noise.

Labyrinthitis otitis interna which involves inflammation of the labyrinths

Labyrinthitis, also known as vestibular neuritis, is the inflammation of the inner ear. It results in a sensation of the world spinning and also possible hearing loss or ringing in the ears. It can occur as a single attack, a series of attacks, or a persistent condition that diminishes over three to six weeks. It may be associated with nausea, vomiting, and eye nystagmus.

Endolymph

Endolymph is the fluid contained in the membranous labyrinth of the inner ear. The major cation in endolymph is potassium, with the values of sodium and potassium concentration in the endolymph being 0.91 mM and 154 mM, respectively. It is also called Scarpa's fluid, after Antonio Scarpa.

Vestibular schwannoma Human disease

A vestibular schwannoma (VS) is a benign primary intracranial tumor of the myelin-forming cells of the vestibulocochlear nerve. A type of schwannoma, this tumor arises from the Schwann cells responsible for the myelin sheath that helps keep peripheral nerves insulated. Although it is also called an acoustic neuroma, this is a misnomer for two reasons. First, the tumor usually arises from the vestibular division of the vestibulocochlear nerve, rather than the cochlear division. Second, it is derived from the Schwann cells of the associated nerve, rather than the actual neurons (neuromas).

Benign paroxysmal positional vertigo disorder arising from a problem in the inner ear

Benign paroxysmal positional vertigo (BPPV) is a disorder arising from a problem in the inner ear. Symptoms are repeated, brief periods of vertigo with movement, that is, of a spinning sensation upon changes in the position of the head. This can occur with turning in bed or changing position. Each episode of vertigo typically lasts less than one minute. Nausea is commonly associated. BPPV is one of the most common causes of vertigo.

Hyperacusis is a highly debilitating hearing disorder characterized by an increased sensitivity to certain frequencies and volume ranges of sound. A person with severe hyperacusis has difficulty tolerating everyday sounds, which become painful or loud.

Tinnitus retraining therapy (TRT) is a form of habituation therapy designed to help people who suffer from tinnitus, a ringing, buzzing, hissing, or other sound in the ears when no external sound is present. Two key components of TRT directly follow from the neurophysiological model of tinnitus. One of these principles includes directive counseling aimed at reclassification of tinnitus to a category of neutral signals, while the other includes sound therapy which is aimed at weakening tinnitus related neuronal activity.

Betahistine chemical compound

Betahistine, sold under the brand name Serc among others, is an anti-vertigo medication. It is commonly prescribed for balance disorders or to alleviate vertigo symptoms, e.g. those associated with Ménière's disease. It was first registered in Europe in 1970 for the treatment of Ménière's disease.

Cinnarizine chemical compound

Cinnarizine is an antihistamine and calcium channel blocker of the diphenylmethylpiperazine group. It is also known to promote cerebral blood flow, and so is used to treat cerebral apoplexy, post-trauma cerebral symptoms, and cerebral arteriosclerosis. However, it is more commonly prescribed for nausea and vomiting due to motion sickness or other sources such as chemotherapy, vertigo, or Ménière's disease.

A neurectomy is a type of nerve block involving the severing or removal of a nerve. This surgery is performed in rare cases of severe chronic pain where no other treatments have been successful, and for other conditions such as involuntary twitching and excessive blushing or sweating.

Labyrinthine fistula

A labyrinthine fistula is an abnormal opening in the bony capsule of the inner ear, resulting in leakage of the perilymph from the cochlea into the middle ear. This includes specifically a perilymph fistula (PLF), an abnormal connection between the fluid of the inner ear and the air-filled middle ear. This connection is caused by a rupture of the round window that separates the inner and middle ear. Another type of labyrinthine fistula is a semicircular canal dehiscence, which allows the inner ear to be influenced by the intracranial pressure directly.

Endolymphatic hydrops is a disorder of the inner ear. It consists of an excessive build-up of the endolymph fluid, which fills the hearing and balance structures of the inner ear. Endolymph fluid, which is partly regulated by the endolymph sac, flows through the inner ear and is critical to the function of all sensory cells in the inner ear. In addition to water, endolymph fluid contains salts such as sodium, potassium, chloride and other electrolytes. If the inner ear is damaged by disease or injury, the volume and composition of the endolymph fluid can change, causing the symptoms of endolymphatic hydrops.

Superior canal dehiscence syndrome (SCDS) is a set of hearing and balance symptoms, related to a rare medical condition of the inner ear, known as superior canal dehiscence. The symptoms are caused by a thinning or complete absence of the part of the temporal bone overlying the superior semicircular canal of the vestibular system. There is evidence that this rare defect, or susceptibility, is congenital. There are also numerous cases of symptoms arising after physical trauma to the head. It was first described in 1998 by Lloyd B. Minor of Johns Hopkins University in Baltimore.

Autoimmune inner ear disease human disease

Autoimmune inner ear disease (AIED) was first defined by Dr. Brian McCabe in a landmark paper describing an autoimmune loss of hearing. The disease results in progressive sensorineural hearing loss (SNHL) that acts bilaterally and asymmetrically, and sometimes affects an individual's vestibular system. AIED is used to describe any disorder in which the inner ear is damaged as a result of an autoimmune response. Some examples of autoimmune disorders that have presented with AIED are Cogan's syndrome, relapsing polychondritis, systemic lupus erythematosus, granulomatosis with polyangiitis, polyarteritis nodosa, Sjogren's syndrome, and Lyme disease.

Vestibular migraine (VM) is vertigo associated with a migraine, either as a symptom of migraine or as a related but neurological disorder; when referred to as a disease unto itself, it is also termed migraine-associated vertigo (MAV), migrainous vertigo, or migraine-related vestibulopathy.

Neurotology or neuro-otology is a branch of clinical medicine which studies and treats neurological disorders of the ear. It is a subspecialty of otolaryngology-head and neck surgery, and is closely related to otology, and also draws on the fields of neurology and neurosurgery. Otology generally refers to the treatment of middle ear disease and resultant conductive hearing loss, whereas neurotology refers to treatment of inner ear conditions, or hearing and balance disorders. These specialists also work with audiologists and related sensory specialists.

Endolymphatic sac tumor

An endolymphatic sac tumor (ELST) is a very uncommon papillary epithelial neoplasm arising within the endolymphatic sac or endolymphatic duct. This tumor shows a very high association with von Hippel-Lindau syndrome (VHL).

References

  1. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 Lopez-Escamez, Jose A.; Carey, John; Chung, Won-Ho; Goebel, Joel A.; Magnusson, Måns; Mandalà, Marco; Newman-Toker, David E.; Strupp, Michael; Suzuki, Mamoru (2015). "Diagnostic criteria for Menière's disease". Journal of Vestibular Research: Equilibrium & Orientation. 25 (1): 1–7. doi:10.3233/VES-150549. ISSN   1878-6464. PMID   25882471.
  2. Dictionary.com Unabridged Archived 3 December 2010 at the Wayback Machine (v 1.1). Random House, Inc. Accessed on 9 September 2008
  3. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 "Ménière's Disease". NIDCD. 1 June 2016. Archived from the original on 27 July 2016. Retrieved 18 July 2016.
  4. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 Seemungal, Barry; Kaski, Diego; Lopez-Escamez, Jose Antonio (August 2015). "Early Diagnosis and Management of Acute Vertigo from Vestibular Migraine and Ménière's Disease". Neurologic Clinics. 33 (3): 619–628, ix. doi:10.1016/j.ncl.2015.04.008. ISSN   1557-9875. PMID   26231275.
  5. 1 2 3 4 5 6 7 8 9 10 11 12 13 Harcourt J, Barraclough K, Bronstein AM (2014). "Meniere's disease". BMJ (Clinical Research Ed.). 349: g6544. doi:10.1136/bmj.g6544. PMID   25391837.
  6. 1 2 Salt AN, Plontke SK (2010). "Endolymphatic hydrops: pathophysiology and experimental models". Otolaryngologic Clinics of North America. 43 (5): 971–83. doi:10.1016/j.otc.2010.05.007. PMC   2923478 . PMID   20713237.
  7. National Institutes of Health (NIH): Ménière's Disease, NIH Publication No. 10–3404, July 2010, last updated June 1, 2016. Archived 27 July 2016 at the Wayback Machine
  8. 1 2 Gürkov R, Pyykö I, Zou J, Kentala E (2016). "What is Menière's disease? A contemporary re-evaluation of endolymphatic hydrops". Journal of Neurology. 263 Suppl 1: 71–81. doi:10.1007/s00415-015-7930-1. PMC   4833790 . PMID   27083887.
  9. Naganawa S, Nakashima T (2014). "Visualization of endolymphatic hydrops with MR imaging in patients with Ménière's disease and related pathologies: current status of its methods and clinical significance". Japanese Journal of Radiology. 32 (4): 191–204. doi:10.1007/s11604-014-0290-4. PMID   24500139.
  10. Mom T, Pavier Y, Giraudet F, Gilain L, Avan P (2015). "Measurement of endolymphatic pressure". European Annals of Otorhinolaryngology, Head and Neck Diseases. 132 (2): 81–4. doi:10.1016/j.anorl.2014.05.004. PMID   25467202.
  11. Sheldrake J, Diehl PU, Schaette R (2015). "Audiometric characteristics of hyperacusis patients". Frontiers in Neurology. 6: 105. doi:10.3389/fneur.2015.00105. PMC   4432660 . PMID   26029161.
  12. Chi, John J.; Ruckenstein, Michael J. (2010). "Chapter 6: Clinical Presentation of Ménière's disease". In Ruckenstein, Michael. Ménière's disease: evidence and outcomes. San Diego, California Abingdon, England: Plural Publishing, Inc. p. 34. ISBN   978-1-59756-620-9.
  13. Tyler RS, Pienkowski M, Roncancio ER, et al. (2014). "A review of hyperacusis and future directions: part I. Definitions and manifestations" (PDF). American Journal of Audiology. 23 (4): 402–19. doi:10.1044/2014_AJA-14-0010. PMID   25104073.
  14. 1 2 3 4 Foster, Carol A. (2015). "Optimal management of Ménière's disease". Therapeutics and Clinical Risk Management. 11: 301–307. doi:10.2147/TCRM.S59023. ISSN   1176-6336. PMC   4348125 . PMID   25750534.
  15. Weinreich, Heather M.; Agrawal, Yuri (June 2014). "The Link Between Allergy and Menière's Disease". Current Opinion in Otolaryngology & Head and Neck Surgery. 22 (3): 227–230. doi:10.1097/MOO.0000000000000041. ISSN   1068-9508. PMC   4549154 . PMID   24573125.
  16. Crowson, Matthew G.; Patki, Aniruddha; Tucci, Debara L. (May 2016). "A Systematic Review of Diuretics in the Medical Management of Ménière's Disease". Otolaryngology–Head and Neck Surgery. 154 (5): 824–834. doi:10.1177/0194599816630733. ISSN   1097-6817. PMID   26932948.
  17. 1 2 Pullens, B; van Benthem, PP (16 March 2011). "Intratympanic gentamicin for Ménière's disease or syndrome". The Cochrane Database of Systematic Reviews (3): CD008234. doi:10.1002/14651858.CD008234.pub2. PMID   21412917.
  18. Huon, Leh-Kiong; Fang, Te-Yung; Wang, Pa-Chun (July 2012). "Outcomes of intratympanic gentamicin injection to treat Ménière's disease". Otology & Neurotology. 33 (5): 706–714. doi:10.1097/MAO.0b013e318259b3b1. PMID   22699980.
  19. 1 2 Espinosa-Sanchez, JM; Lopez-Escamez, JA (2016). "Menière's disease". Handbook of clinical neurology. 137: 257–77. doi:10.1016/B978-0-444-63437-5.00019-4. PMID   27638077.
  20. Clendaniel, R. A.; Tucci, D. L. (December 1997). "Vestibular rehabilitation strategies in Meniere's disease". Otolaryngologic Clinics of North America. 30 (6): 1145–1158. ISSN   0030-6665. PMID   9386249.
  21. Orji, Ft (2014). "The Influence of Psychological Factors in Meniere's Disease". Annals of Medical and Health Sciences Research. 4 (1): 3–7. doi:10.4103/2141-9248.126601. ISSN   2141-9248. PMC   3952292 . PMID   24669323.
  22. Greenberg, Simon L.; Nedzelski, Julian M. (October 2010). "Medical and noninvasive therapy for Meniere's disease". Otolaryngologic Clinics of North America. 43 (5): 1081–1090. doi:10.1016/j.otc.2010.05.005. ISSN   1557-8259. PMID   20713246.
  23. 1 2 Lim, Ming Yann; Zhang, Margaret; Yuen, Heng Wai; Leong, Jern-Lin (November 2015). "Current evidence for endolymphatic sac surgery in the treatment of Meniere's disease: a systematic review". Singapore Medical Journal. 56 (11): 593–598. doi:10.11622/smedj.2015166. ISSN   0037-5675. PMC   4656865 . PMID   26668402.
  24. Sood, Amit Justin; Lambert, Paul R.; Nguyen, Shaun A.; Meyer, Ted A. (July 2014). "Endolymphatic sac surgery for Ménière's disease: a systematic review and meta-analysis". Otology & Neurotology. 35 (6): 1033–1045. doi:10.1097/MAO.0000000000000324. ISSN   1537-4505. PMID   24751747.
  25. 1 2 Walther LE (2005). "Procedures for restoring vestibular disorders". GMS Current Topics in Otorhinolaryngology, Head and Neck Surgery. 4: Doc05. PMC   3201005 . PMID   22073053.
  26. 1 2 3 Pullens, Bas; Verschuur, Hendrik P.; van Benthem, Peter Paul (2013). "Surgery for Ménière's disease". The Cochrane Database of Systematic Reviews (2): CD005395. doi:10.1002/14651858.CD005395.pub3. ISSN   1469-493X. PMID   23450562.
  27. James, A. L.; Burton, M. J. (2001). "Betahistine for Menière's disease or syndrome". The Cochrane Database of Systematic Reviews (1): CD001873. doi:10.1002/14651858.CD001873. ISSN   1469-493X. PMID   11279734.
  28. Adrion, C; Fischer, C. S.; Wagner, J; Gürkov, R; Mansmann, U; Strupp, M; Bemed Study, Group (2016). "Efficacy and safety of betahistine treatment in patients with Meniere's disease: Primary results of a long term, multicentre, double blind, randomised, placebo controlled, dose defining trial (BEMED trial)". BMJ. 352: h6816. doi:10.1136/bmj.h6816. PMC   4721211 . PMID   26797774.
  29. van Sonsbeek S, Pullens B, van Benthem PP. Positive pressure therapy for Ménière's disease or syndrome. Cochrane Database Syst Rev. 2015 Mar 10;(3):CD008419. doi : 10.1002/14651858.CD008419.pub2 PMID   25756795
  30. Syed, M. I.; Rutka, J. A.; Hendry, J; Browning, G. G. (2015). "Positive pressure therapy for Meniere's syndrome/disease with a Meniett device: A systematic review of randomised controlled trials". Clinical Otolaryngology. 40 (3): 197–207. doi:10.1111/coa.12344. PMID   25346252.
  31. Hu, A; Parnes, L. S. (2009). "Intratympanic steroids for inner ear disorders: A review". Audiology and Neurotology. 14 (6): 373–82. doi:10.1159/000241894. PMID   19923807.
  32. Miller MW, Agrawal Y (2014). "Intratympanic Therapies for Menière's disease". Current Otorhinolaryngology Reports. 2 (3): 137–143. doi:10.1007/s40136-014-0055-8. PMC   4157672 . PMID   25215266.
  33. 1 2 Iwasaki, Shinichi; Yamasoba, Tatsuya (February 2015). "Dizziness and Imbalance in the Elderly: Age-related Decline in the Vestibular System". Aging and Disease . 6 (1): 38–47. doi:10.14336/AD.2014.0128. ISSN   2152-5250. PMC   4306472 . PMID   25657851.
  34. Ishiyama G et al. Meniere's disease: histopathology, cytochemistry, and imaging. Ann N Y Acad Sci. 2015 Apr;1343:49-57. doi : 10.1111/nyas.12699. PMID   25766597
  35. Méniere (1861) "Sur une forme de surdité grave dépendant d’une lésion de l’oreille interne" Archived 16 February 2016 at the Wayback Machine (On a form of severe deafness dependent on a lesion of the inner ear), Bulletin de l'Académie impériale de médecine, 26 : 241.
  36. 1 2 3 4 Beasley NJ, Jones NS (December 1996). "Menière's disease: evolution of a definition". J Laryngol Otol. 110 (12): 1107–13. doi:10.1017/S002221510013590X. PMID   9015421.
Classification
D
External resources